|Resident Hong Kong Partners|
Davis Polk & Wardwell
Hong Kong Solicitors
The Hong Kong Club Building
3A Chater Road
|852 2533 3300 tel||
James C. Lin*
Patrick S. Sinclair*
|Hong Kong Solicitors|
* Also Admitted in New York
Also Admitted in England and Wales
|June 4, 2020|
Re: Genetron Holdings Limited (CIK No. 0001782594)
Registration Statement on Form F-1 (File No. 333-234805)
Mr. Ruairi Regan
Ms. Brigitte Lippmann
Division of Corporation Finance
CF Office of Real Estate & Construction
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Ladies and Gentlemen:
On behalf of our client, Genetron Holdings Limited (the Company), an exempted company incorporated under the laws of the Cayman Islands, we submit to the staff (the Staff) of Securities and Exchange Commission (the Commission) this letter in connection with the Companys registration statement on Form F-1 initially filed on November 21, 2019 (the Registration Statement). Concurrently with the submission of this letter, the Company is filing its amendment No. 1 to the Registration Statement (the Amended Registration Statement) and certain exhibits via EDGAR with the Commission. On behalf of the Company, we wish to thank you and other members of the Staff for your prompt response to the Companys request for comments.
To facilitate your review, we have separately delivered to you four courtesy copies of the Amended Registration Statement, marked to show changes to the Registration Statement, and two copies of the submitted exhibits.
|2||June 4, 2020|
The Company has included the financial results for the year ended December 31, 2019 and for the three months ended March 31, 2020 and other information and data in the Registration Statement to reflect recent developments.
The Company currently plans on filing an amendment to the Registration Statement containing the estimated price range and offering size on or around June 12, 2020 and launching the road show as soon as legally permissible after that, subject to market conditions. The Company would greatly appreciate the Staffs continuing assistance and support in meeting its timetable.
* * * *
|3||June 4, 2020|
If you have any questions regarding this submission, please contact me at +852-2533-3306 (email@example.com) and/or Xuelin (Steve) Wang at +852-2533-1092 (firstname.lastname@example.org).
Thank you for your time and attention.
Mr. Sizhen Wang, Chief Executive Officer
Mr. Evan Ce Xu, Chief Financial Officer
Genetron Holdings Limited
Mr. Fang Liu, Esq.
Clifford Chance US LLP
PricewaterhouseCoopers Zhong Tian LLP